Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
42
NBBTF Quote, Financials, Valuation and Earnings
Last price:
$0.06
Seasonality move
:
-11.87%
Day range:
$0.06 - $0.06
52-week range:
$0.05 - $0.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.16x
P/B ratio:
1.91x
Volume:
--
Avg. volume:
83
1-year change:
4.54%
Market cap:
$127.7M
Revenue:
$45.3M
EPS (TTM):
-$0.00
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Natural Beauty Bio-Technology Ltd. has -- downside to fair value with a price target of -- per share.
NBBTF vs. S&P 500
-
Over the past 5 trading days, Natural Beauty Bio-Technology Ltd. has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Natural Beauty Bio-Technology Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Natural Beauty Bio-Technology Ltd. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Natural Beauty Bio-Technology Ltd. reported revenues of --.
Earnings Growth
-
Natural Beauty Bio-Technology Ltd. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Natural Beauty Bio-Technology Ltd. reported earnings per share of --.
Enterprise value:
131.3M
EV / Invested capital:
--
Price / LTM sales:
2.16x
EV / EBIT:
--
EV / Revenue:
2.22x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
-23.46x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$29.7M
Return On Assets:
-7.67%
Net Income Margin (TTM):
-13.49%
Return On Equity:
-12.86%
Return On Invested Capital:
-9.32%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2016-12-31 | 2017-12-31 | |
| Income Statement | ||||||
| Revenue | $65.4M | $61.2M | $51.2M | $140.7M | $123.5M | |
| Gross Profit | $51.3M | $45.5M | $39.1M | -$10.6M | -$4.1M | |
| Operating Income | $20.5M | $22.3M | $18.8M | -$20.6M | -$8.7M | |
| EBITDA | $20.5M | $22.3M | $18.8M | $40.9M | -$256M | |
| Diluted EPS | $0.01 | $0.01 | $0.01 | -$0.04 | -$0.31 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $57.3M | $53.2M | $44.4M | $38.4M | $41.5M | |
| Total Assets | $114M | $110.6M | $109.2M | $105.3M | $108.5M | |
| Current Liabilities | $30.6M | $32.3M | $34.3M | $36.4M | $28.6M | |
| Total Liabilities | $32.9M | $35.6M | $36.6M | $37.9M | $46.8M | |
| Total Equity | $81.1M | $75M | $72.7M | $67.4M | $61.7M | |
| Total Debt | $10.8M | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-06-30 | 2012-06-30 | 2013-06-30 | 2012-06-30 | 2013-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $27.6M | $12.9M | $9M | $2.8M | $4.1M | |
| Cash From Investing | -$4.6M | -$5.6M | -$5.3M | -$1.7M | -$496.2K | |
| Cash From Financing | -$20.6M | -$21.9M | -- | -$12.9M | -- | |
| Free Cash Flow | $21.7M | $5.3M | $2.8M | $51.2K | $3.1M | |
NBBTF
Sector
Market Cap
$127.7M
$125M
Price % of 52-Week High
66.15%
71.8%
Dividend Yield
0%
0%
Shareholder Yield
--
2.32%
1-Year Price Total Return
4.54%
-7.14%
Beta (5-Year)
-0.077
0.257
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.06
200-day SMA
Sell
Level
$0.06
Bollinger Bands (100)
Sell
Level
0.05 - 0.07
Chaikin Money Flow
Sell
Level
-5.2K
20-day SMA
Sell
Level
$0.06
Relative Strength Index (RSI14)
Buy
Level
52.76
ADX Line
Buy
Level
29.53
Williams %R
Neutral
Level
-63.6239
50-day SMA
Sell
Level
$0.06
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
44K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.012)
Buy
CA Score
(Annual)
Level (-0.0385)
Buy
Beneish M-Score
(Annual)
Level (-3.2452)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (1.2684)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Natural Beauty Bio-Technology Ltd. is an investment holding company, which engages in the manufacture and sales of skin care, beauty, and aroma therapeutic products, health supplements, and make-up products. It also engages in the provision of skin treatments, beauty and spa services, medical cosmetology services, skin care consulting, and beauty training. It operates through the following geographic segments: The PRC, Taiwan, and Others. The company was founded by Tsai Yen-Yu on January 1, 1976 and is headquartered in Hong Kong.
Stock Forecast FAQ
In the current month, NBBTF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NBBTF average analyst price target in the past 3 months is --.
-
Where Will Natural Beauty Bio-Technology Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Natural Beauty Bio-Technology Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Natural Beauty Bio-Technology Ltd.?
Analysts are divided on their view about Natural Beauty Bio-Technology Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Natural Beauty Bio-Technology Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Natural Beauty Bio-Technology Ltd.'s Price Target?
The price target for Natural Beauty Bio-Technology Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NBBTF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Natural Beauty Bio-Technology Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NBBTF?
You can purchase shares of Natural Beauty Bio-Technology Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Natural Beauty Bio-Technology Ltd. shares.
-
What Is The Natural Beauty Bio-Technology Ltd. Share Price Today?
Natural Beauty Bio-Technology Ltd. was last trading at $0.06 per share. This represents the most recent stock quote for Natural Beauty Bio-Technology Ltd.. Yesterday, Natural Beauty Bio-Technology Ltd. closed at $0.06 per share.
-
How To Buy Natural Beauty Bio-Technology Ltd. Stock Online?
In order to purchase Natural Beauty Bio-Technology Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NBBTF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NBBTF
Sector
P/E ratio
--
16.71x
PEG ratio
-0.03x
0.13x
P/B ratio
1.91x
1.48x
Price / LTM sales
2.16x
0.51x
Growth Metrics
NBBTF
Sector
Revenue growth
--
2.99%
Earnings growth
--
5.39%
Revenue (5-year growth)
-4.13%
3.32%
Earnings forecast
--
$0.32
Profitability
NBBTF
Sector
Profitability FY 2024
$23.1M
$263.1M
Return on invested capital
-9.32%
4.38%
Return on assets
-7.67%
3.07%
Return on equity
-12.86%
7.5%
Earnings Date
Last Earnings Date
Dec
22
Next Earnings Date
Dec
22
Estimated Next Earnings Date
Mar
23
Balance Sheet
NBBTF
Sector
Total cash
$12.4M
$87.3M
Short term investments
--
$32.9M
Total assets
$100.4M
$1.1B
Long term debt
--
$6.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
